Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE CENTRALE DE COMMERCY : revenue, balance sheet and financial ratios

SELARL PHARMACIE CENTRALE DE COMMERCY is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in COMMERCY (55200), this company of category PME shows in 2025 a net income positive of 326 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE CENTRALE DE COMMERCY (SIREN 829503978)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 326 124 € 360 272 € 337 406 € 380 465 € 391 908 € 288 261 € 395 678 € 195 690 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE CENTRALE DE COMMERCY generates positive net income of 326 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 196 k€ -> 326 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

326 124 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 40%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

39.906%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.451%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.1%

Solvency indicators evolution
SELARL PHARMACIE CENTRALE DE COMMERCY

Sector positioning

Debt ratio
39.91 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good

In 2025, the debt ratio of SELARL PHARMACIE CENTRALE... (39.91) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
66.45% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good +8 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE CENTRALE... (66.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 374.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

374.93

Liquidity indicators evolution
SELARL PHARMACIE CENTRALE DE COMMERCY

Sector positioning

Liquidity ratio
374.93 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent

In 2025, the liquidity ratio of SELARL PHARMACIE CENTRALE... (374.93) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELARL PHARMACIE CENTRALE DE COMMERCY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE CENTRALE DE COMMERCY is estimated at 5 180 518 € (range 3 515 524€ - 8 128 946€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
3515k€ 5180k€ 8128k€
5 180 518 € Range: 3 515 524€ - 8 128 946€
NAF 5 année 2025

Valuation method used

Net Income Multiple
326 124 € × 15.9x = 5 180 518 €
Range: 3 515 524€ - 8 128 947€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE CENTRALE DE COMMERCY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE CENTRALE DE COMMERCY

What is the revenue of SELARL PHARMACIE CENTRALE DE COMMERCY ?

The revenue of SELARL PHARMACIE CENTRALE DE COMMERCY is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE CENTRALE DE COMMERCY profitable?

Yes, SELARL PHARMACIE CENTRALE DE COMMERCY generated a net profit of 326 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE CENTRALE DE COMMERCY ?

The headquarters of SELARL PHARMACIE CENTRALE DE COMMERCY is located in COMMERCY (55200), in the department Meuse.

Where to find the tax return of SELARL PHARMACIE CENTRALE DE COMMERCY ?

The tax return of SELARL PHARMACIE CENTRALE DE COMMERCY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE CENTRALE DE COMMERCY operate?

SELARL PHARMACIE CENTRALE DE COMMERCY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.